Location: Home
  • search
  • go
  • Relate News
  • 6/7/2022NH's DB6: Top Ten Chinese CHC Brands in 2021
  • 6/7/2022NH's DB6: Chinese OTC Drug Market Forecast 2026/2031
  • 5/26/2022Data Snapshot: Top 20 Domestic Class 1 New Drugs by Sales in 2021
  • 5/26/2022Ten Trends of China's Pharmaceutical Industry in 2021 (PharmCube)
  • 5/23/2022IQVIA: Chinese Hospital Drug Market Rose 4.2% in Q1/2021
  • 5/20/2022U.S., European Firms Rethink China Investment After Lockdowns
  • 5/17/2022433 Listed Chinese Pharma Companies Report Their Annual Performance in...
  • 5/13/2022Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2021
  • 5/11/2022China Rolls Out Five Year Plan to Develop $3.28 Trillion Bioeconomy ...
  • 5/11/2022Review of Top 10 Listed Chinese Biotech Firms by R&D Spending in 2021
  • 5/9/2022SMEI: Review of Chinese Terminal Drug Markets in 2011 – 2021
  • 5/4/2022How American Companies are Approaching China's Data, Privacy, and Cybe...
  • 4/29/2022Adagene-Sanofi's $2.5B Deal Tops March Deals in China (PharmaDJ)
  • 4/28/2022Sales Expenditures of Listed Chinese Pharma Companies Sharply Up Again...
  • 4/28/2022SMEI Revises Down Chinese Pharma Industry Growth Projection in 2022
  • 4/28/2022Sanofi Reports Q1/2022 Performance, Witnessing 13.4% Growth in China
  • 4/26/2022AstraZeneca Remain Bullish on Long-term Development in China
  • 4/19/202234 HK-Listed Chinese Biopharma Firms Saw Sharp Revenue Growth in 2021 ...
  • 4/14/2022PhIIC: Chinese Retail Biologics Sales Led by Anti-tumor Drugs in 2021
  • 4/11/2022Clinical Development Strategies for Western Biotech Companies in China...
  • 4/10/2022Market Segmentation Snapshot of Chinese Retail Drug Market 2019-2021
  • 4/10/2022Chinese Pharma Profits Fell Sharply in the First Two Months of 2022
  • 3/30/2022IQVIA: Chinese Biopharma Investment Hotspots and Sustainability
  • 3/21/2022As AZ Sounds the Slowdown Alarm in China, Jefferies Beats the Drum for...
  • 3/14/2022China Healthcare Investment Now Up To 30% Of Global Total (PharmaDJ)
  • 3/10/2022AmCham Survey, U.S. Firms Less Optimistic About Making New Investments...
  • 3/9/2022Snapshot of MNC Pharma's China Performance in 2021 (Updated)
  • 2/28/2022Most MNCs and Domestics Face Serious Headwinds, But Some Managed to Ex...
  • 2/26/2022IQVIA: Chinese Hospital Drug Market Rose 2.2% in MAT Q4/2021
  • 2/22/2022Eli Lilly Fared Well in China Last Year Despite Slowing Q4 Growth over...
  • Page:10/38 Total number of articles:1139: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group